NCLT: Suspended Directors Who are Prospective Resolution Applicants Cann’t Access Valuation Reports  ||  Supreme Court Clarifies Test For Granting Bail to Accused Added at Trial under Section 319 CrPC  ||  SC: Fresh Notification For Vijayawada ACB Police Station not Required After AP Bifurcation  ||  SC: Studying in a Government Institute Does Not Create an Automatic Right to a Government Job  ||  NCLT Mumbai: CIRP Claims Cannot Invoke the 12-Year Limitation Period For Enforcing Mortgage Rights  ||  NCLAT: Misnaming Guarantor as 'Director' in SARFAESI Notice Doesn't Void Guarantee Invocation  ||  Jharkhand HC: Mere Breach of Compromise Terms by an Accused Does Not Justify Bail Cancellation  ||  Cal HC: Banks Cannot Freeze a Company's Accounts Solely Due To ROC Labeling a 'Management Dispute'  ||  Rajasthan HC: Father’s Rape of His Daughter Transcends Ordinary Crime; Victim’s Testimony Suffices  ||  Delhi HC: Judge Who Reserved Judgment Must Deliver Verdict Despite Transfer; Successor Can't Rehear    

#Economic Survey 2021-2022: Overview of Pharmaceutical Sector - (31 Jan 2022)

BANKING

In the April-September 2021 period, the FDI inflows in the Pharmaceutical Sector continued to be at Rs 4,413 Crores, growing at the rate of 53%. Further, the Survey has pointed out that India is significantly dependent on the import of bulk drugs that are used in the formulation of medicines.

Tags : ECONOMIC SURVEY   PHARMACEUTICAL SECTOR  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved